Human Cytomegalovirus Latency and Reactivation in Allogeneic Hematopoietic Stem Cell Transplant Recipients

Frontiers in Microbiology - Switzerland
doi 10.3389/fmicb.2019.01186
Full Text
Abstract

Available in full text

Categories
Microbiology
Date
Authors
Publisher

Frontiers Media SA

Related search

Cidofovir for Cytomegalovirus Infection and Disease in Allogeneic Stem Cell Transplant Recipients

Blood
BiochemistryImmunologyCell BiologyHematology
2001English

Transplant-Associated Microangiopathy (TAM) in Recipients of Allogeneic Hematopoietic Stem Cell Transplants

Bone Marrow Transplantation
TransplantationHematology
2005English

Use of Cytomegalovirus Intravenous Immune Globulin for the Adjunctive Treatment of Cytomegalovirus in Hematopoietic Stem Cell Transplant Recipients

Pharmacotherapy
Pharmacology
2010English

Medication Adherence Among Allogeneic Hematopoietic Stem Cell Transplant Recipients: A Pilot Single-Center Study

Bone Marrow Transplantation
TransplantationHematology
2017English

Rethinking the Use of Voriconazole Therapeutic Drug Monitoring in Allogeneic Hematopoietic Stem Cell Transplant Recipients

Bone Marrow Transplantation
TransplantationHematology
2005English

CMV and EBV DNA Kinetics in Whole Blood and Plasma of Allogeneic Hematopoietic Stem Cell Transplant Recipients

Biology of Blood and Marrow Transplantation
TransplantationHematology
2018English

Central Nervous System Aspergillosis in Allogeneic Stem Cell Transplant Recipients

Bone Marrow Transplantation
TransplantationHematology
2003English

Management of Cytomegalovirus (CMV) in Hematopoietic Stem Cell Transplant (HSCT)

Journal of Pediatrics & Neonatal Care
2014English

Drug Resistant CMV in Pediatric Hematopoietic Stem Cell Transplant Recipients

Biology of Blood and Marrow Transplantation
TransplantationHematology
2015English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy